Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1992 1
1998 1
1999 1
2001 1
2002 2
2003 1
2004 2
2005 4
2006 4
2007 5
2008 5
2009 3
2010 2
2011 6
2012 1
2013 4
2014 1
2015 6
2016 3
2017 3
2018 5
2019 5
2020 3
2021 3
2022 15
2023 9
2024 11
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group.
Mirioglu S, Daniel-Fischer L, Berke I, Ahmad SH, Bajema IM, Bruchfeld A, Fernandez-Juarez GM, Floege J, Frangou E, Goumenos D, Griffith M, Moran SM, van Kooten C, Steiger S, Stevens KI, Turkmen K, Willcocks LC, Kronbichler A. Mirioglu S, et al. Nephrol Dial Transplant. 2024 Mar 27;39(4):569-580. doi: 10.1093/ndt/gfae025. Nephrol Dial Transplant. 2024. PMID: 38341276 Free PMC article.
Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations.
Casal Moura M, Gauckler P, Anders HJ, Bruchfeld A, Fernandez-Juarez GM, Floege J, Frangou E, Goumenos D, Segelmark M, Turkmen K, van Kooten C, Tesar V, Geetha D, Fervenza FC, Jayne DRW, Stevens KI, Kronbichler A. Casal Moura M, et al. Nephrol Dial Transplant. 2023 Oct 31;38(11):2637-2651. doi: 10.1093/ndt/gfad090. Nephrol Dial Transplant. 2023. PMID: 37164940 Free PMC article.
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.
Gauckler P, Matyjek A, Kapsia S, Marinaki S, Quintana LF, Diaz MM, King C, Griffin S, Ramachandran R, Odler B, Eller K, Artan AS, Mirioglu S, Busch M, Schaepe M, Turkmen K, Cheung CK, Pepper RJ, Juarez GF, Pascual J, Auñón P, García-Carro C, Rodriguez A, Alberici F, Luzardo L, Chebotareva N, Schönermarck U, Fernández L, Radhakrishnan J, Guaman K, Peleg Y, Hoisnard L, Audard V, Papasotiriou M, Krnanska N, Tesar V, Hruskova Z, Bruchfeld A, Stangou M, Lioulios G, Faguer S, Ribes D, Salhi S, Windpessl M, Galešić K, Crnogorac M, Zagorec N, Mayer G, Kronbichler A; RITERM Study Team. Gauckler P, et al. J Am Soc Nephrol. 2025 Apr 1;36(4):668-678. doi: 10.1681/ASN.0000000520. Epub 2024 Oct 16. J Am Soc Nephrol. 2025. PMID: 39431468
Over the 36 months of follow-up, a stable course of eGFR was observed in those who initially responded with either complete or partial remission, whereas nonresponders experienced a reduction in eGFR reaching 11 (95% CI, 18 to 8) ml/min per 1.73 m(2). CONCLUSIONS: Rituxima …
Over the 36 months of follow-up, a stable course of eGFR was observed in those who initially responded with either complete or partial remis …
The EANM guideline for radiosynoviorthesis.
Kampen WU, Boddenberg-Pätzold B, Fischer M, Gabriel M, Klett R, Konijnenberg M, Kresnik E, Lellouche H, Paycha F, Terslev L, Turkmen C, van der Zant F, Antunovic L, Panagiotidis E, Gnanasegaran G, Kuwert T, Van den Wyngaert T; EANM Bone & Joint Committee, the Dosimetry Committee, the Oncology & Theranostics Committee. Kampen WU, et al. Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):681-708. doi: 10.1007/s00259-021-05541-7. Epub 2021 Oct 20. Eur J Nucl Med Mol Imaging. 2022. PMID: 34671820 Free PMC article.
Risk assessment in patients with symptomatic and asymptomatic pre-excitation.
Jemtrén A, Saygi S, Åkerström F, Asaad F, Bourke T, Braunschweig F, Carnlöf C, Drca N, Insulander P, Kennebäck G, Nordin AP, Sadigh B, Rickenlund A, Saluveer O, Schwieler J, Svennberg E, Tapanainen J, Turkmen Y, Bastani H, Jensen-Urstad M. Jemtrén A, et al. Europace. 2024 Feb 1;26(2):euae036. doi: 10.1093/europace/euae036. Europace. 2024. PMID: 38363996 Free PMC article.
Prognostic factors and validation of the histologic chronicity score for C3 glomerulopathy: a registry analysis.
Mirioglu S, Cebeci E, Yazici H, Derici U, Sahin G, Coban G, Eren N, Gungor O, Dede F, Dincer T, Turkmen K, Basturk T, Duranay M, Arikan H, Tunca O, Elcioglu OC, Tatar E, Aydin Z, Oygar D, Demir S, Tanrisev M, Kurultak I, Oruc A, Turkmen A, Akcay OF, Cetinkaya H, Ozturk S; Glomerular Diseases Working Group of the Turkish Society of Nephrology (TSN-GOLD). Mirioglu S, et al. Clin Kidney J. 2024 Mar 20;17(8):sfae077. doi: 10.1093/ckj/sfae077. eCollection 2024 Aug. Clin Kidney J. 2024. PMID: 39421234 Free PMC article.
Experimental Study of a Quad-Band Metamaterial-Based Plasmonic Perfect Absorber as a Biosensor.
Korkmaz S, Oktem E, Yazdaanpanah R, Aksu S, Turkmen M. Korkmaz S, et al. Molecules. 2022 Jul 18;27(14):4576. doi: 10.3390/molecules27144576. Molecules. 2022. PMID: 35889446 Free PMC article.
We present a metamaterial-based perfect absorber (PA) that strongly supports four resonances covering a wide spectral range from 1.8 m to 10 m of the electromagnetic spectrum. The designed perfect absorber has metal-dielectric-metal layers where a MgF(2) spacer is s …
We present a metamaterial-based perfect absorber (PA) that strongly supports four resonances covering a wide spectral range from 1.8 m …
99 results